Company potenitial is great - however the issue of communication quality of Anns, Brr's and timelines has fallen in a heap. and needs to be looked at and reviewd by CVI management
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling